Placental development requires extensive angiogenesis and the invasion of the maternal decidua by the trophoblasts. Adequate and organized interaction of vascular endothelial growth factors (VEGF), placenta growth factors (PlGF), and their receptors are essential for a normal development and function of the placenta. In this study, we evaluated the expressions of PlGFs and their receptors, mRNAs by Northern blotting, in situ hybridization and RT-PCR in the normal and pregnancy-induced hypertensive (PIH) placentas. The expression level of PlGF-2 mRNA was lower in the PIH placentas compared to control as assessed by Northern blotting and in situ hybridization. PlGF mRNA was mainly localized to the vasculosyncytial membrane of placental villi and villous stroma. The expression of PlGF receptor-1 (PlGFR-1) was significantly increased in the PIH placentas compared to the normal ones. These results suggest that the alteration of PlGF-2 and PlGFR-1 mRNA expressions in the placenta are related to the pathogenesis of PIH.
INTRODUCTION
Pregnancy-induced hypertension (PIH) usually develops during the second half of the pregnancy and accompanies proteinuria and edema. PIH is estimated to affect 7 to 10% of all pregnancies in the United States (1), making common complications associated with feto-maternal death and morbidity.
While the etiology of PIH remains unclear, it is known to be associated with endothelial damage and dysfunction (2) . There are also an increased concentration of vasoconstrictive agents such as endothelin (3) , increased capillary permeability (4) , and the endothelial damage is also associated with neutrophil (5) .
An impaired trophoblastic invasion of the maternal placental bed is considered to be the initiator of endothelial damage in PIH (6) . This defect might result in poor fetoplacental perfusion along with a release of factors into the maternal circulation, leading to a widespread endothelial damage and the resulting clinical symptoms of PIH (7) . This placental dysfunction could be mediated by the factors present in the maternal circulation as a result of impaired trophoblastic invasion (6) . Angiogenic growth factors are also thought to play a substantial role in the placentation, and can be strong endothelial cell activators (8) .
Recently, placenta growth factor (PlGF), a dimeric secreted factor that shares close amino acid homology (53% identity) to vascular endothelial growth factor (VEGF), was known as a potent angiogenic growth factor capable of inducing the proliferation, migration, and activation of endothelial cells (9) . Unlike VEGF, abundant expression of PlGF is restricted to the placenta (10) . Alternative splicing of PlGF mRNA produces at least three polypeptides, PlGF-1, PlGF-2 and PlGF-3, which have different secretory patterns, heparinbinding affinities and dimerization properties (10, 11) .
Ideal placental development requires an adequate and organized interaction of vascular growth factors and their receptors, including VEGF and PlGF; both VEGF and PlGF act through their common tyrosine kinase receptors (12) . The expression of VEGF and KDR (PlGFR-2/VEGFR-2) is strongest during early gestation and decrease as pregnancy advances (13) (14) (15) while PlGF and Flt-1 (PlGFR-1/ VEGFR-1) increase towards term (16, 17) . In the present study, we examined the expression patterns and localization of PlGFs and their recep-tors in the normal and PIH human placentas at term to get insight into their relation to PIH.
MATERIALS AND METHODS
Tissue collection and preparation for in situ hybridization Placentas used for analyses were collected from 8 normal [37 (4 cases), 38 (2 cases), 39 wk (2 cases)] and 5 PIH [36 (2 cases), 37, 38, 39 wk] mothers at caesarean section delivery in Gyeongsang National University Hospital (GNUH). The Human Subject Research Committee of GNUH approved these human tissues for the present study. The parameters to define PIH were systolic, and diastolic blood pressures above 140 and 90 mmHg, respectively, in at least two consecutive measurement, and proteinuria of >0.3 g/24 hr, in women after 20-week of gestation. The placentas (approximate weight: 100 mg) were snap frozen in liquid nitrogen immediately after collection for total RNA extraction. For in situ hybridization, the placentas were dissected on ice, cut into cubes fit into slide glass, and washed with phosphate buffered saline (PBS, pH 7.0). And then those tissues were post-fixed by a 48 hrimmersion in 4% neutrally buffered paraformaldehyde and cryoprotected by immersion in 20% sucrose in PBS for 24 hr. The tissues were frozen using OCT compound (Sakura Finetek, CA, U.S.A.), and 12 m sections were cut with a cryostat (Leica, Heidelberger, Germany) and thaw-mounted on gelatin-coated slides, dried and stored at -70 until use.
Hematoxylin and eosin staining
The frozen sections were washed with tap water for 5 min, immersed in hematoxylin for 2 min and checked for complete staining in tap water. Eosin staining was carried out for 3 min. Sections were dehydrated through a graded series of alcohol (70 to 100% ethanol, 3 min each), cleared in xylene, coverslipped and observed with a light microscope.
Northern blot analysis
Total RNA was extracted from placenta, using acid guanidium thiocyanate-phenol chloroform method, and quantified by UV spectrophotometer. Twenty micrograms of total RNA was subjected to electrophoresis in a 1.2% agaroseformaldehyde gel and then capillary-transferred to a nylon membranes (Nytran, pore size: 0.45 m, Schleicher & Schuell, Keene, NK). The partial cDNAs of human PlGF-1/-2 were obtained form human placenta using RT-PCR and cloning. Then we confirmed PlGF cDNAs after sequence analysis and used as template for probe synthesis. Probes were labeled by random priming with [ 32 P]-dCTP, and purified with a Sephadex G-50 nick column (Pharmacia Biotech, Uppsala, Sweden). Hybridization was carried out for 16-18 hr at 42 in 20 mL of hybridization buffer [50% Deionized Formamide, 5 SSPE (20 SSPE: 3 M NaCl, 0.2 M NaH2PO4, and 20 mM EDTA, pH 7.4), 5 Denhardt' s solution (1 Denhardts solution, 0.02% polyvinyl-pyrolidone, 0.02% Ficoll, 0.02% BSA), 0.1% SDS, 1 mg/mL heated-denatured salmon sperm DNA]. Membranes were washed in 2 SSPE with 0.1% SDS at room temperature for 10 min twice and in 0.1 SSPE with 0.1% SDS at 42 for 10 min. The membranes were exposed to radiography film (Fuji RX & Fuji Co, Tokyo, Japan) for 3 days at -70
In situ hybridization
The 35 S-UTP-labeled probes were generated by in vitro transcription from partial cDNA clone amplified from PIH placentas. The probes were purified with Sephadex G-50 nick column and radioactivity was measured on a -counter. Prehybridization was carried out for 1 hr at 37 in prehybridization buffer [50% Deionized Formamide, 0.25 M NaCl, 1 Denhardts solution, 10 mM Tris (pH 8.0), 1 mM EDTA (pH 8.0), 10% Dextran Sulfate, yeast tRNA (250 g/ mL), 50 mM DTT]. Hybridization of the slides with antisense 35 S-UTP-labeled RNA transcripts (7 10 5 cpm per section) in prehybridization buffer was performed at 60 for 20 hr. Sections were washed in 4 SSC, treated with 20 g/mL of RNase A, washed in 2 SSC, and followed with a further wash in 0.1 SSC containing 1.0 M DTT at room temperature. Sections were dehydrated through a graded series of alcohol (50% to 100% ethanol) and air dried at room temperature, then autoradiographed for 7 days at -70 using Amersham -max hyperfilm (Amersham, NJ, U.S.A.). Slides were then dipped in NTB2 autoradiographic emulsion (Kodak, NY, U.S.A.) and exposed in the dark at 4 for 14 days, and developed with D-19 developer, fixed with rapid fixer (both from Kodak, NY, U.S.A.), counterstained with cresyl violet, and mounted. were added. The PCR reaction mixture was subjected to 30 cycles of amplification using a PCR system with denaturation at 94 for 1 min, primer-annealing at 55 for 1 min, and primer-extension at 72 for 2 min. PCR products (10 L) were subjected to electrophoresis in a 1.2% agarose gel in TAE buffer, visualized by UV illumination after ethidium bromide staining, and photographed using Polaroid 667 film (Hertfordshire, U.K.). -actin was used as a internal control for procedual variation. The intensity of PCR bands was measured densitometrically and analyzed using SigmaGel (version 1.0, Jandel Scientic Software) software.
RT-PCR analysis of

Statistics
RT-PCR signals were normalized to their -actin signals. One-way analysis of variance was determined using Graphpad Instat Software (Version 1.15). A p value<0.05 was deemed statistically significant; data are expressed as mean SEM.
RESULTS
H & E staining in the normal and PIH placentas
Representative hematoxylin and eosin-stained sections of the normal and PIH placentas were shown in Fig. 1 . In the PIH placenta, specific histologic changes were seen compared to control; the syncytial membranes were continuously expanded and the number of syncytial knots was increased in the PIH placental villi.
Expression of PlGF-1 and PlGF-2 mRNAs in the normal and PIH placentas
Northern blot analyses were conducted to evaluate differences in the abundance of PlGF-1 and PlGF-2 mRNA in normal and PIH placentas. Both PlGF-1 and PlGF-2 mRNAs were less abundant in PIH placenta compared to normal (Fig. 2) ; of two genes, the PlGF-2 was markedly decreased (Fig. 2B) . and a 1.7-kb (PlGF-2) transcript in the normal and PIH placenta after a hybridization with PlGF-1-and PlGF-2-specific cDNA probes, respectively. PlGF2 mRNA is markedly decreased in the PIH placenta compared to the normal placenta. Twenty micrograms of total RNA from the pool of 8 normal and 5 PIH placentas was applied to each lane, and the consistency in loading is demonstrated by ethidium-bromide staining of 18S rRNA. PlGF-1, placenta growth factor -1; PlGF-2, placenta growth factor -2.
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Localization of PlGF-1 and PlGF-2 mRNAs in the normal and PIH placentas by in situ hybridization
The PlGF-1 (data not shown) and PlGF-2 mRNAs were localized in the vasculosyncytial membrane and the villous stroma of placental villi in the normal (Fig. 3A) and PIH placenta (Fig. 3B) . While no significant difference was detected in the expression of PlGF-1 mRNA between normal (Fig.  3a) and PIH placentas (Fig. 3b) , the expression of PlGF-2 mRNA was decreased in the PIH placenta (Fig. 3d) compared to the normal one (Fig. 3c) .
Expression of PlGFR-1 and PlGFR-2 mRNAs in the normal and PIH placentas
The mRNAs encoding PlGFR-1 and PlGFR-2 were detected by RT-PCR in both the normal and PIH placentas. While the expression of PlGFR-1 was significantly higher in the PIH placentas compared to the normal one (p<0.05) (Fig. 4A,  B) , that of PlGFR-2 showed no significant difference (Fig. 4C,   D) . Relative densities were normalized by -actin signals.
DISCUSSION
Although many theories have been proposed to explain the development of PIH, most of previous reports have not provided a clear picture. What is known, to date, is that PIH originates in the placenta and involves vasospasm of blood vessels in both mother and the placenta causing damage to the interior lining of blood vessels; its association with endothelial damage and dysfunction has been reported (2) .
PlGFs, angiogenic growth factors, and their receptors are essential for placental vascular development (12) . In this study, we examined the expression level of PlGF-1 and PlGF-2 mRNAs in both the normal and PIH placentas at term and found a decreased mRNA level of PlGF-2 in PIH placentas by Northern blots and in situ hybridization. This result agrees well with previous reports; serum PlGF level was significantly lower in PIH as compared to normal pregnancies (18, 19) the transcription of PlGF-2 mRNA in the placenta and decidua from PIHs decreased significantly (20) . Biological activities of PlGF-2 are mediated by the PlGFR-1 (21, 22) . Three cell types in the placenta express the PlGFR-1; endothelial cells, Hoffbauer cells and trophoblasts, with extravillous trophoblast showing particularly high expression (23) . In normal pregnancies, fetal trophoblasts invade the maternal decidua and remodel the spiral arteries, converting them to lower resistant vessels. In pregnancies complicated by preeclampsia, this trophoblastic cell invasion is inadequate, resulting in poor placental perfusion and fetal hypoxia (24, 25) . The increased syncytial knots in the PIH placenta (Fig. 1 ) compared to normal one implicate an inadequate invasion of trophoblastic cells and this may be caused by a lower level of PlGF-2.
We revealed higher level of PlGFR-1 in the PIH placenta compared to normal one using RT-PCR and this was also consistent with other reports (19, 26) ; PlGFR-1, but not the other receptors, showed increased expression in the placental syncytiotrophoblasts among 50% of patients with severe preeclampsia compared to normal ones (19) . Helske et al. (19) suggested that the increased PlGFR-1 expression is probably not a specific change of characteristic for pre-eclampsia, but is possibly associated with abnormal placental function and hypoxia. It was also revealed that trophoblastic cells express both insoluble PlGFR-1 and soluble PlGFR-1, and the soluble form PlGFR-1 have an antagonistic regulation function of its ligands (27) . Therefore, the inadequate development of chorionic villi after mid gestation in PIH placenta may be possibly due to the lower level of PlGF mRNA and higher level of PlGFR-1 mRNA.
In the human placenta, VEGF, PlGF and their receptors are differentially expressed throughout gestation: VEGF and PlGFR-2 are most intense during early gestation and decline as pregnancy advances (13) (14) (15) while PlGF and PlGFR-1 increase towards term (16, 17) . Correlation of these growthfactor effects and their expression patterns throughout gestation with a development of a villous angioarchitecture (28, 29) suggest that VEGF and PlGFR-2 are involved in the first two trimesters of pregnancy in the establishment of the richly branched capillary beds of the mesenchymal and immature intermediate villi while PlGF and PlGFR-1 are more likely to be involved in the formation of the long, poorly branched, terminal capillary loops in the last trimester (30) .
Although PlGF itself does not significantly stimulate angiogenesis in vivo and in vitro, this growth factor modulates the angiogenic activity of VEGF by forming PlGF/VEGF heterodimers (31) . Therefore, the amount of VEGF is also important in complicated placenta etiology. However, recent reports provide conflicting conclusions regarding the expression of VEGF in pre-eclamptic pregnancies; at the RNA level, VEGF expression was found to decrease in single biopsy samples of pre-eclamptic placentas as compared to biopsies from normal placentas (32) ; VEGF protein levels in serum of pre- eclamptic women were found to be elevated in some studies (33, 34) while others have reported decreased levels (35), relative to normal pregnant women; PlGF homodimers are themselves angiogenic (36) and may also function to enhance the activity of suboptimal concentrations of VEGF (21) . Furthermore, naturally occurring VEGF/PlGF heterodimers maintain high-affinity receptor binding and mitogenic activity on HUVE cells (37) . While VEGF binds with high affinity to both PlGFR-2 and PlGFR-1, PlGF exhibits high affinity only to PlGFR-1 (21) . Therefore, it is suggested that the main cause of delicate placental complications is PlGF rather than VEGF considering its amount consistency in complicated pregnancy placenta and its specificity to PlGFR-1. Especially, the adequate PlGF-2 mRNA expression level in placenta seems to be essential for normal placenta morphometric development in late pregnancy.
